EP2895163A1 — Compositions comprising peg and ascorbate
Assigned to Norgine BV · Expires 2015-07-22 · 11y expired
What this patent protects
The invention provides acolon cleansing solutioncomprising: a) 300 to 800 mmol per litre ascorbate anion provided by a mixtureof: (i) ascorbic acid and (ii) one or more salts of ascorbic acid the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and b…
USPTO Abstract
The invention provides acolon cleansing solutioncomprising: a) 300 to 800 mmol per litre ascorbate anion provided by a mixtureof: (i) ascorbic acid and (ii) one or more salts of ascorbic acid the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and b) 10 to 200 g per litre polyethylene glycol. The invention also provides methods an kits associated with, or making use of the solutions, and compositions for the preparation of the solutions.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.